SCHEMBL975152

SCHEMBL975152

CCC(=O)N1CCN(CC(=O)NC2CCCCC2)CC1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.68
CA1 P00915 2/20 0.68
CA2 P00918 2/20 0.68
CA9 Q16790 2/20 0.68
SIGMAR1 Q99720 8/20 0.64
CHRM5 P08912 3/20 0.64
EPHX2 P34913 2/20 0.64
CHRM3 P20309 2/20 0.64
ALDH1A1 P00352 2/20 0.56
MAPK1 P28482 1/20 0.56
TSHR P16473 2/20 0.54
POLB P06746 1/20 0.54
PKM P14618 1/20 0.54
CHRM1 P11229 2/20 0.53
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11010870 0.81 SIGMAR1 (0.91) CA12CA1CA2CA9SIGMAR1
SCHEMBL1555698 0.81 SIGMAR1 (0.76) CA12CA1CA2CA9SIGMAR1
SCHEMBL6479844 0.81 SIGMAR1 (0.75) CA12CA1CA2CA9SIGMAR1
SCHEMBL23612751 0.80 SIGMAR1 (0.71) CA12CA1CA2CA9SIGMAR1
SCHEMBL19034848 0.80 SIGMAR1 (0.71) CA12CA1CA2CA9SIGMAR1
SCHEMBL19636761 0.80 SIGMAR1 (0.71) CA12CA1CA2CA9SIGMAR1
Esaprazole SCHEMBL931007 0.78 SIGMAR1 (1.00) CA12CA1CA2CA9SIGMAR1
SCHEMBL2730613 0.78 EPHX2 (1.00) EPHX2
SCHEMBL2719520 0.78 EPHX2 (1.00) EPHX2
SCHEMBL1557134 0.78 SIGMAR1 (0.65) CA12CA1CA2CA9SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO claimed
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed